US 12,239,361 B2
Method for denervation with reduced pain
David R. Fischell, Fair Haven, NJ (US); and Steven Almany, Bloomfield Hills, MI (US)
Assigned to Ablative Solutions, Inc., Wakefield, MA (US)
Filed by Ablative Solutions, Inc., Wakefield, MA (US)
Filed on Oct. 25, 2022, as Appl. No. 18/049,443.
Application 18/049,443 is a continuation of application No. 16/717,286, filed on Dec. 17, 2019, granted, now 11,510,729.
Application 16/717,286 is a continuation of application No. 15/947,460, filed on Apr. 6, 2018, granted, now 10,517,666, issued on Dec. 31, 2019.
Application 15/947,460 is a continuation in part of application No. 14/963,179, filed on Dec. 8, 2015, granted, now 9,949,652, issued on Apr. 24, 2018.
Application 14/963,179 is a continuation in part of application No. 14/063,907, filed on Oct. 25, 2013, granted, now 9,931,046, issued on Apr. 3, 2018.
Prior Publication US 2023/0071511 A1, Mar. 9, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 3/02 (2006.01); A61B 5/00 (2006.01); A61B 5/05 (2021.01); A61B 5/20 (2006.01); A61B 5/388 (2021.01); A61B 17/22 (2006.01); A61B 17/32 (2006.01); A61B 18/06 (2006.01); A61B 18/14 (2006.01); A61B 90/00 (2016.01); A61M 31/00 (2006.01); A61B 5/021 (2006.01); A61B 5/024 (2006.01); A61B 18/00 (2006.01); A61B 18/02 (2006.01); A61B 18/04 (2006.01); A61B 18/18 (2006.01); A61M 25/00 (2006.01); A61N 7/02 (2006.01)
CPC A61B 18/1477 (2013.01) [A61B 5/201 (2013.01); A61B 5/388 (2021.01); A61B 5/6852 (2013.01); A61B 17/2202 (2013.01); A61B 17/320068 (2013.01); A61B 18/06 (2013.01); A61B 18/1492 (2013.01); A61B 90/39 (2016.02); A61B 5/021 (2013.01); A61B 5/024 (2013.01); A61B 5/6848 (2013.01); A61B 2017/22014 (2013.01); A61B 2018/00214 (2013.01); A61B 2018/00404 (2013.01); A61B 2018/00434 (2013.01); A61B 2018/00511 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/00666 (2013.01); A61B 2018/00738 (2013.01); A61B 2018/00779 (2013.01); A61B 2018/00791 (2013.01); A61B 2018/00827 (2013.01); A61B 2018/00839 (2013.01); A61B 2018/00875 (2013.01); A61B 2018/00892 (2013.01); A61B 2018/00898 (2013.01); A61B 2018/0212 (2013.01); A61B 18/0218 (2013.01); A61B 2018/046 (2013.01); A61B 2018/1425 (2013.01); A61B 2018/143 (2013.01); A61B 2018/1432 (2013.01); A61B 18/1815 (2013.01); A61B 2090/3966 (2016.02); A61M 2025/0087 (2013.01); A61N 7/022 (2013.01)] 23 Claims
OG exemplary drawing
 
1. A method comprising:
advancing a distal portion of a catheter having at least three needle guide elements and at least three needles to a site within a human body;
advancing the at least three needle guide elements to expand outwardly against tissue within the human body, wherein the at least three needle guide elements are configured to maintain their position against the tissue;
advancing the at least three needles through the at least three needle guide elements into the tissue, wherein the at least three needle guide elements are configured to maintain their position against the tissue as the at least three needles are advanced into the tissue; and
ablating sympathetic nerve fibers while minimizing or eliminating pain to the patient.